We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

XenoGesis and BioAscent Forge Alliance to Offer Enhanced Integrated Drug Discovery Services

News   May 22, 2018 | Original story from BioAscent

 
XenoGesis and BioAscent Forge Alliance to Offer Enhanced Integrated Drug Discovery Services

Credit: BioAscent

 
 
 

RELATED ARTICLES

Ebola Patients Have a 90% Survival Rate After Injection With New Drugs

News

Two Ebola drugs have proven so effective in a clinical trial that researchers will make the treatments available to anyone infected with the virus in the Democratic Republic of the Congo, where Ebola has killed nearly 1,900 people over the past year.

READ MORE

Taking Back Control Over Antibiotic Resistant Bacteria

News

Scientists have discovered how molecules called rhamnolipids could make common aminoglycoside antibiotics effective against the toughest Staph infections.

READ MORE

Mastering the Tricky Task of Measuring Tiny Nanoparticles

News

Researchers have determined that measuring the range of sizes in nanoparticles — instead of just the average particle size — is optimal for most applications.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Biopharma Cell Science

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE